Generative AI in Drug Discovery: Revolutionizing Pharmaceutical Research and Development

The generative AI in drug discovery market is experiencing significant expansion, growing from $0.25 billion in 2025 to $0.33 billion in 2026, with projections to reach $0.86 billion by 2030 at a 27% CAGR. Key drivers include rising drug development costs, computational chemistry advancements, increased biological datasets, and strategic collaborations between AI firms and pharmaceutical companies. Major players are leveraging AI-driven tools for molecule generation, deep learning in drug design, and accelerated early-stage development.

07/10/2026, 10:55 AM • GlobeNewswire

Molecular Biology Enzymes, Reagents and Kits Market Size Worth USD 70.85 Billion by 2035 | SNS Insider

The global molecular biology enzymes, reagents and kits market is projected to grow from USD 27.69 billion in 2025 to USD 70.85 billion by 2035, with a CAGR of 9.68%. Growth is driven by increasing adoption of precision medicine, molecular diagnostics, genomics research, and biotechnology R&D. The US market is expected to reach $23.54 billion and Europe $19.32 billion by 2035, with Asia-Pacific showing the fastest growth.

07/03/2026, 6:48 AM • GlobeNewswire

Global Single-use Bioreactors Market Forecast to Surge from USD 3.61 Billion in 2025 to USD 15.11 Billion by 2034

The global single-use bioreactors market is projected to experience robust growth with a CAGR of 17.27%, expanding from USD 3.61 billion in 2025 to USD 15.11 billion by 2034. Growth is driven by increasing biopharmaceutical demand, cost efficiency advantages, and technological advancements in bioprocessing. North America is expected to dominate, while Asia-Pacific shows rapid expansion. Major players include Sartorius, Thermo Fisher Scientific, and Cytiva, with recent developments including new product launches and facility expansions.

07/03/2026, 5:12 AM • GlobeNewswire

Global Pharmaceutical Filtration Market to Double by 2034: Insights on Driving Factors

The global pharmaceutical filtration market is expected to grow at a CAGR of 8.13% from 2025 to 2034, driven by rising biopharmaceutical demand, CDMO expansion, and increased sterile drug manufacturing. North America leads the market, while Asia-Pacific emerges as a rapidly growing region. Major players are investing in capacity expansion and acquisitions to meet growing demand, though high operational costs and filter clogging challenges persist.

07/03/2026, 4:43 AM • GlobeNewswire

Global Sterile Bioprocess Filtration Market Set to Surge, Projected to Reach USD 31.33 Billion by 2034

The global sterile bioprocess filtration market is projected to grow from USD 6.50 billion in 2025 to USD 31.33 billion by 2034, at a CAGR of 19.13%. Growth is driven by rising biopharmaceutical and vaccine demand, outsourcing to CMOs/CDMOs, and technological advancements. North America is expected to lead the market, with membrane filters dominating the product segment.

07/03/2026, 4:42 AM • GlobeNewswire

Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider

The global Oxidative Stress Assay Market is projected to grow at a CAGR of 9.53% from 2026 to 2035, driven by rising chronic disease prevalence, pharmaceutical R&D investments, and advancements in biomarker diagnostics. North America leads with 38.52% market share, while Asia-Pacific is expected to show the highest growth rate at 10.55%. ELISA technology dominates with 39% market share, and cancer research accounts for 33% of revenue.

06/28/2026, 10:30 PM • GlobeNewswire

Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer

Bio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies within three years.

06/25/2026, 5:23 PM • The Motley Fool

Dimethylformamide Market Size to Hit USD 4.54 Billion by 2035 as Pharmaceutical and Industrial Demand Expands | SNS Insider

The global dimethylformamide (DMF) market is projected to grow from USD 2.79 billion in 2025 to USD 4.54 billion by 2035, at a CAGR of 4.98%. Growth is driven by pharmaceutical API manufacturing expansion in India and China, synthetic leather production in Asia Pacific, and electronics-grade DMF demand. Industrial grade dominates with 58.4% market share, while pharmaceutical grade is the fastest-growing segment at 7.9% CAGR. North America leads with 38.9% revenue share, while Europe faces REACH regulatory compliance pressures.

06/20/2026, 5:30 AM • GlobeNewswire

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

The global protein synthesis research market is experiencing accelerating growth driven by increased investment in cell and gene therapy research, rising chronic disease prevalence, and expanding healthcare budgets. North America leads with 42.8% market share, while Asia-Pacific infrastructure expansion presents significant growth opportunities. Key market drivers include strong late-stage therapy pipelines and government support through initiatives like the CHIPS and Science Act.

05/18/2026, 2:33 PM • GlobeNewswire

Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight

The myasthenia gravis market is projected to grow from USD 6 billion in 2025 to over USD 16 billion by 2036, driven by rising diagnosed prevalence, improved diagnostics, and an expanding pipeline of targeted biologic therapies including FcRn inhibitors, complement inhibitors, and CAR-T cell therapies. The market is currently led by argenx and UCB, with numerous emerging candidates in late-stage development expected to significantly accelerate growth.

05/18/2026, 1:00 PM • GlobeNewswire

Organic Semiconductor Market Size to Worth USD 1175.68 Billion by 2035 | Research by SNS Insider

The organic semiconductor market is experiencing significant growth, with projections showing the market reaching USD 301.74 billion by 2035 at a CAGR of 20.05%. Key drivers include advancements in molecular stacking processes improving energy efficiency and brightness in OLED displays. Polymeric organic semiconductors currently dominate with 61.40% market share, while small molecule semiconductors are expected to grow fastest. Asia Pacific leads with 45.40% market share, while North America shows the fastest growth rate at 19.51% CAGR.

05/14/2026, 3:30 AM • GlobeNewswire

[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global cell culture media bags market is valued at USD 1.30 billion in 2025 and is projected to reach USD 2.28 billion by 2035, growing at a CAGR of 5.8%. Growth is driven by increased R&D investments in life sciences, adoption of single-use bioprocessing technologies, and automation trends in biopharmaceutical manufacturing. Single-use bags and EVA materials dominate the market segments, with North America leading in market share and Asia Pacific showing the highest growth rate.

04/29/2026, 12:30 AM • GlobeNewswire

Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight

The generalized myasthenia gravis (gMG) market is experiencing significant growth with 8 promising late-stage drug candidates in development. The gMG market across 7 major markets was valued at USD 5.9 billion in 2025 and is projected to grow at 9.1% CAGR through 2036. Key therapies in development include FcRn inhibitors, complement inhibitors, BTK inhibitors, and innovative CAR-T cell therapies from major pharmaceutical companies.

04/15/2026, 1:00 PM • GlobeNewswire

Zinc Chloride Market Size to Surpass USD 509.55 Million by 2035, Driven by Demand from Batteries, Water Treatment, and Chemical Applications | Report by SNS Insider

The global zinc chloride market is projected to grow from USD 336.16 million in 2025 to USD 509.55 million by 2035, with a CAGR of 4.29%. Growth is driven by demand from dry cell battery production, water treatment applications, and chemical manufacturing. The U.S. market is expected to grow from USD 120.76 million to USD 176.66 million, while Asia Pacific shows the fastest growth at 5.29% CAGR.

04/08/2026, 2:37 AM • GlobeNewswire

[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

The global Pharmaceutical Microbiology QC Testing Market is projected to grow from USD 5.08 billion in 2025 to USD 17.65 billion by 2035, at a CAGR of 13.27%. Growth is driven by increased regulatory oversight, laboratory automation, antimicrobial resistance concerns, and adoption of advanced technologies like AI-enabled molecular platforms and MALDI-TOF mass spectrometry. North America leads with 39.12% market share, while Asia Pacific is expected to grow fastest at 14.33% CAGR.

03/10/2026, 2:00 PM • GlobeNewswire